Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-22
1993-04-13
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483114, A61K 31415, C07D40306
Patent
active
052023435
ABSTRACT:
The invention relates to compounds of the general formula (I): ##STR1## wherein Im represents an imidazolyl group of the formula: ##STR2## R.sup.1 represents a hydrogen atom or a group selected from C.sub.1-6 alkyl, C.sub.3-6 alkenyl, C.sub.3-10 alkynyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkylC.sub.1-4 alkyl, phenyl, phenylC.sub.1-3 alkyl, --CO.sub.2 R.sup.5, --COR.sup.5, --CONR.sup.5 R.sup.6 or --SO.sub.2 R.sup.5 ;
REFERENCES:
patent: 4808581 (1989-02-01), Oxford et al.
patent: 4814344 (1989-03-01), Humber et al.
patent: 4822881 (1989-04-01), Coates et al.
patent: 4859662 (1989-08-01), Coates et al.
patent: 4950681 (1990-08-01), Cavalla et al.
Bell James A.
Bradshaw John
Coates Ian H.
Ewan George B.
Humber David C.
Glaxo Group Limited
Lee Mary C.
Miltenberger Lenora Ava
LandOfFree
Tricyclic ketones useful as HT.sub.3 -receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic ketones useful as HT.sub.3 -receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic ketones useful as HT.sub.3 -receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155668